BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 2541899)

  • 1. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
    Hébert CD; Birnbaum LS
    Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
    Woodworth CD; Chung J; McMullin E; Plowman GD; Simpson S; Iglesias M
    Cell Growth Differ; 1996 Jun; 7(6):811-20. PubMed ID: 8780894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
    Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
    Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies of the role of transforming growth factor-beta in human B cell function.
    Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
    J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
    Kumar A; Rogers T; Maizel A; Sharma S
    J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of transforming growth factor beta in the proliferative effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on human squamous carcinoma cells.
    Hébert CD; Cao QL; Birnbaum LS
    Cancer Res; 1990 Nov; 50(22):7190-7. PubMed ID: 2171758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium.
    Yamanishi H; Nonomura N; Tanaka A; Yasui T; Nishizawa Y; Matsumoto K; Sato B
    Cancer Res; 1990 Oct; 50(19):6179-83. PubMed ID: 2169337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
    Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
    J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Valverius EM; Walker-Jones D; Bates SE; Stampfer MR; Clark R; McCormick F; Dickson RB; Lippman ME
    Cancer Res; 1989 Nov; 49(22):6269-74. PubMed ID: 2553252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
    Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
    Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environment-dependent growth inhibition of human epidermal keratinocytes by recombinant human transforming growth factor-beta.
    Rollins BJ; O'Connell TM; Bennett G; Burton LE; Stiles CD; Rheinwald JG
    J Cell Physiol; 1989 Jun; 139(3):455-62. PubMed ID: 2472411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
    Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
    J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of high affinity receptors for type beta transforming growth factor during differentiation of murine embryonal carcinoma cells.
    Rizzino A
    Cancer Res; 1987 Aug; 47(16):4386-90. PubMed ID: 2886219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes.
    Vivien D; Galéra P; Lebrun E; Loyau G; Pujol JP
    J Cell Physiol; 1990 Jun; 143(3):534-45. PubMed ID: 2358472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
    Carr BI; Hayashi I; Branum EL; Moses HL
    Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of transforming growth factor beta 1 on the growth of poorly and highly metastatic murine melanoma cells.
    Mooradian DL; Purchio AF; Furcht LT
    Cancer Res; 1990 Jan; 50(2):273-7. PubMed ID: 2295066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.